Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases

PD Talukdar, U Chatterji - Signal Transduction and Targeted Therapy, 2023 - nature.com
Specific cell states in metazoans are established by the symphony of gene expression
programs that necessitate intricate synergic interactions between transcription factors and …

[HTML][HTML] E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases

L Lu, C Jifu, J Xia, J Wang - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Ferroptosis is a form of cell death mediated by iron and lipid peroxidation (LPO). Recent
studies have provided compelling evidence to support the involvement of ferroptosis in the …

Lineage-specific intolerance to oncogenic drivers restricts histological transformation

EE Gardner, EM Earlie, K Li, J Thomas, MJ Hubisz… - Science, 2024 - science.org
Lung adenocarcinoma (LUAD) and small cell lung cancer (SCLC) are thought to originate
from different epithelial cell types in the lung. Intriguingly, LUAD can histologically transform …

Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN

X Zhang, X Cong, X Jin, Y Liu, T Zhang, X Fan… - Cell Death & …, 2023 - nature.com
The transcription factor MYCN is frequently amplified and overexpressed in a variety of
cancers including high-risk neuroblastoma (NB) and promotes tumor cell proliferation …

Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors

M Sanati, AR Afshari, SS Ahmadi, SA Moallem… - …, 2023 - Wiley Online Library
Regarding the multimechanistic nature of cancers, current chemo‐or radiotherapies often
fail to eradicate disease pathology, and frequent relapses or resistance to therapies occur …

Small cell lung cancer plasticity enables NFIB-independent metastasis

JH Ko, KE Lambert, D Bhattacharya, MC Lee, CI Colón… - Cancer Research, 2024 - AACR
Metastasis is a major cause of morbidity and mortality in patients with cancer, highlighting
the need to identify improved treatment and prevention strategies. Previous observations in …

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease

SM Johnson, J Haberberger, J Galeotti… - Blood Cancer …, 2023 - nature.com
Dear Editor, Emerging evidence supports that ASXL1 mutation in myeloid neoplasia leads to
aberrant protein gain-of-function rather than loss-of-function as initially thought [1]. Thus, a …

BAP1 in cancer: epigenetic stability and genome integrity

S Caporali, A Butera, I Amelio - Discover Oncology, 2022 - Springer
Mutations in BAP1 have been identified in a hereditary cancer predisposition syndrome and
in sporadic tumours. Individuals carrying familiar BAP1 monoallelic mutations display …

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma

J Hwang, HE Lee, JS Han, MH Choi, SH Hong… - Scientific Reports, 2024 - nature.com
Although sex differences have been reported in patients with clear cell renal cell carcinoma
(ccRCC), biological sex has not received clinical attention and genetic differences between …

Recent advances in the development of deubiquitinases inhibitors as antitumor agents

LL Zheng, LT Wang, YW Pang, LP Sun, L Shi - European Journal of …, 2024 - Elsevier
Ubiquitination is a type of post-translational modification that covalently links ubiquitin to a
target protein, which plays a critical role in modulating protein activity, stability, and …